Home Newsfeeds Gordon Haskett Upgrades TJX Companies to Buy, Announces $80 Price Target

Gordon Haskett Upgrades TJX Companies to Buy, Announces $80 Price Target

Gordon Haskett analyst Chuck Grom upgrades TJX Companies (NYSE:TJX) from Hold to Buy and announces $80 price target.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Gordon Haskett analyst Chuck Grom upgrades TJX Companies (NYSE:TJX) from Hold to Buy and announces $80 price target.

Acushnet Holdings Q3 EPS $0.72 Beats $0.58 Estimate, Sales $558.20M Beat $518.42M Estimate

By Benzinga Newsdesk

November 3, 6:13 AM

Acushnet Holdings (NYSE:GOLF) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.58 by 24.14 percent. This is a 38.46 percent increase over earnings of $0.52 per share from the

GOLF

‘HSBC Acquires Silicon Valley Bank’s UK Arm, Chancellor Jeremy Hunt Confirms’ – Bloomberg UK

By Happy Mohamed

March 13, 3:16 AM

https://www.bloomberg.com/news/live-blog/2023-03-12/svb-fallout-spreads?srnd=premium-europe&utm_medium=social&utm_content=bloomberguk&cmpid%3D=socialflow-twitter-bloomberguk&utm_source=twitter&utm_cam BREAKING: HSBC acquires Silicon Valley Bank's UK arm, Chancellor Jeremy Hunt confirms https://t.co/pkow8qBF5O pic.twitter.com/uzxZwI8ZvW — Bloomberg…

EWU

Citizens Community Q4 EPS $0.45 Beats $0.41 Estimate

By Benzinga Newsdesk

January 23, 5:01 PM

Citizens Community (NASDAQ:CZWI) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.41 by 9.76 percent. This is a 22.41 percent decrease over earnings of $0.58 per share from

CZWI

Mirati To Present Pooled Clinical Data From Adagrasib’s KRYSTAL-1 Study Demonstrating Overall Survival Results At Two-Years Of Follow-Up At 2023 World Conference On Lung Cancer

By Happy Mohamed

August 21, 4:00 PM

Mirati Therapeutics, Inc.® (NASDAQ:MRTX), a commercial stage biotechnology company, today announced a presentation of two-year follow-up from a pooled analysis of the Phase 1/1b Cohort and Phase 2

MRTX

Gordon Haskett Upgrades TJX Companies to Buy, Announces $80 Price Target

Related Posts

Acushnet Holdings Q3 EPS $0.72 Beats $0.58 Estimate, Sales $558.20M Beat $518.42M Estimate

‘HSBC Acquires Silicon Valley Bank’s UK Arm, Chancellor Jeremy Hunt Confirms’ – Bloomberg UK

Citizens Community Q4 EPS $0.45 Beats $0.41 Estimate

Mirati To Present Pooled Clinical Data From Adagrasib’s KRYSTAL-1 Study Demonstrating Overall Survival Results At Two-Years Of Follow-Up At 2023 World Conference On Lung Cancer